Body composition was assessed using the same device; a whole-body fan-beam DXA scan (Hologic Discovery W, software V.12.6, 2; Hologic, Bedford, Massachusetts) which evaluated per cent body fat mass.

Total body CT scan revealed an osteoblastic appearance of the bone ... The reference ranges are reported in Table 1. BMD was measured by DXA using Hologic QDR-4500 (Hologic Inc., Waltham, MA, USA) at ...

Q4 2024 Earnings Call Transcript November 4, 2024 Hologic, Inc. reports earnings inline with expectations. Reported EPS is $1 ...

Analyst Michael Matson from Needham reiterated a Buy rating on Hologic (HOLX – Research Report) and keeping the price target at $90.00.

Hologic, Inc. (NASDAQ:HOLX), a leading medical technology company specializing in women's health, has been the subject of recent analyst scrutiny as it navigates a complex market landscape. The ...

Hologic (HOLX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tejas Savant ...

Hologic, Inc. HOLX reported adjusted earnings ... the expected impact from the ongoing temporary stop-ship of Horizon DXA systems in Skeletal Health. Fiscal 2025 revenues are projected to be ...

The firm reported a 13 percent jump in its non-COVID molecular diagnostics revenues year over year while its breast health and GYN Surgical business revenues rose 6 percent.

RBC Capital raised the firm’s price target on Hologic (HOLX) to $89 from $86 and keeps a Sector Perform rating on the shares after its Q4 results and initial FY25 guidance. The firm contends ...

Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year ...